SCHEMBL29382560

SCHEMBL29382560

O=C(O)c1ccccc1OC1OC(CO)C(O)C(O)C1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A2 P31639 5/20 0.64
SLC5A1 P13866 2/20 0.64
SLC28A3 Q9HAS3 2/20 0.60
ATM Q13315 1/20 0.54
TYR P14679 1/20 0.52
HIF1A Q16665 1/20 0.52
USP2 O75604 4/20 0.51
HKDC1 Q2TB90 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
TNNI3 P19429 2/20 0.51
TNNT2 P45379 2/20 0.51
TNNC1 P63316 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
LMNA P02545 1/20 0.51
GLA P06280 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14164007 1.00 SLC5A2 (0.64) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL244406 1.00 SLC5A2 (0.64) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL8654092 1.00 SLC5A2 (0.64) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL4281885 1.00 SLC5A2 (0.64) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL28176940 1.00 SLC5A2 (0.64) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL8659653 1.00 SLC5A2 (0.64) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL8654543 1.00 SLC5A2 (0.64) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL7039100 0.90 SLC5A2 (0.56) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL1599039 0.90 SLC5A2 (0.56) SLC5A2SLC5A1SLC28A3ATMTYR
SCHEMBL941002 0.88 SLC28A3 (0.62) SLC5A2SLC5A1SLC28A3TYRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024053585-A1 METHOD FOR PRODUCING DESIRED SUBSTANCE USING PLANT HAVING SUPPRESSED RESISTANCE 国立研究開発法人産業技術総合研究所 2024-03-14 WO claimed
WO-2026087419-A1 PROCESS TO EFFICIENTLY RELEASE SUGARS AND/OR PHENOLIC COMPOUNDS FROM PLANT MATERIAL UNIVERSITEIT GENT (BE) 2026-04-30 WO disclosed
US-20260062711-A1 METHOD FOR PRODUCING DESIRED SUBSTANCE USING PLANT HAVING SUPPRESSED RESISTANCE NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2026-03-05 US disclosed
CN-120683189-A Application of beta-glucosidase in preparation of salicylic acid by degrading salicylic acid glucoside 上海依诺基科生物技术有限公司 2025-09-23 CN disclosed
CN-120683189-A Application of beta-glucosidase in preparation of salicylic acid by degrading salicylic acid glucoside 上海依诺基科生物技术有限公司 2025-09-23 CN disclosed
US-12295394-B2 Water-soluble additive composition SUMITOMO BAKELITE CO., LTD. (JP) 2025-05-13 US disclosed
WO-2024053585-A1 METHOD FOR PRODUCING DESIRED SUBSTANCE USING PLANT HAVING SUPPRESSED RESISTANCE 国立研究開発法人産業技術総合研究所 2024-03-14 WO disclosed
CN-113881653-B Tartary buckwheat glycoside hydrolase and encoding gene and application thereof 中国农业科学院作物科学研究所 2023-06-09 CN disclosed
US-11473086-B2 Loss of function alleles of PtEPSP-TF and its regulatory targets in rice UT-BATTELLE, LLC (US) 2022-10-18 US disclosed
US-20220175000-A1 WATER-SOLUBLE ADDITIVE COMPOSITION RESEARCH INSTITUTE OF INNOVATIVE TECHNOLOGY FOR THE EARTH (JP) 2022-06-09 US disclosed
EP-3950910-A1 WATER-SOLUBLE ADDITIVE COMPOSITION Sumitomo Bakelite Co.Ltd. (JP) 2022-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062711-A1 METHOD FOR PRODUCING DESIRED SUBSTANCE USING PLANT HAVING SUPPRESSED RESISTANCE ITPA, IMPA1, ATF4 SLC5A2 4093/4885SLC5A1 4016/4885SLC28A3 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.